Opthea Strengthens Team with Key Clinical and Regulatory Hires
Dr. Julie Clark, SVP Clinical Development; Dr. Fang Li, SVP Regulatory Affairs, to join February 1st
Experienced executives bring extensive track record in products for retinal and ophthalmology diseases
Related news for (OPT)
- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) Reports Full Year 2024 and First Half 2025 Financial Results
- 24/7 Market News Snapshot 06 October, 2025 – Syntec Optics Holdings, Inc. Class A Common Stock (NASDAQ:OPTX)
- Breaking News: MoBot’s Latest Update as of 09/05/25 04:00 PM
- MoBot alert highlights: NASDAQ: ATNF, NASDAQ: ECDA, NASDAQ: BTOG, NASDAQ: ZURA, NYSE: OPTT (07/17/25 12:00 PM)
- Breaking News: MoBot’s Latest Update as of 07/17/25 11:00 AM